320 related articles for article (PubMed ID: 24606796)
1. Biological carrier molecules of radiopharmaceuticals for molecular cancer imaging and targeted cancer therapy.
Aerts A; Impens NR; Gijs M; D'Huyvetter M; Vanmarcke H; Ponsard B; Lahoutte T; Luxen A; Baatout S
Curr Pharm Des; 2014; 20(32):5218-44. PubMed ID: 24606796
[TBL] [Abstract][Full Text] [Related]
2. Economics of New Molecular Targeted Personalized Radiopharmaceuticals.
Cutler CS
Semin Nucl Med; 2019 Sep; 49(5):450-457. PubMed ID: 31470937
[TBL] [Abstract][Full Text] [Related]
3. Targeted radionuclide therapy: frontiers in theranostics.
Gallivanone F; Valente M; Savi A; Canevari C; Castiglioni I
Front Biosci (Landmark Ed); 2017 Jun; 22(10):1750-1759. PubMed ID: 28410143
[TBL] [Abstract][Full Text] [Related]
4. [Development of bifunctional radiopharmaceuticals for targeted imaging and therapy].
Mukai T
Yakugaku Zasshi; 2007 Dec; 127(12):1937-45. PubMed ID: 18057782
[TBL] [Abstract][Full Text] [Related]
5. Cancer nanotargeted radiopharmaceuticals for tumor imaging and therapy.
Ting G; Chang CH; Wang HE
Anticancer Res; 2009 Oct; 29(10):4107-18. PubMed ID: 19846958
[TBL] [Abstract][Full Text] [Related]
6. Liver uptake of radiolabeled targeting proteins and peptides: considerations for targeting peptide conjugate design.
Hosseinimehr SJ; Tolmachev V; Orlova A
Drug Discov Today; 2012 Nov; 17(21-22):1224-32. PubMed ID: 22781499
[TBL] [Abstract][Full Text] [Related]
7. Radionuclide cancer therapy.
Hoefnagel CA
Ann Nucl Med; 1998 Apr; 12(2):61-70. PubMed ID: 9637275
[TBL] [Abstract][Full Text] [Related]
8. A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma.
Bolcaen J; Kleynhans J; Nair S; Verhoeven J; Goethals I; Sathekge M; Vandevoorde C; Ebenhan T
Theranostics; 2021; 11(16):7911-7947. PubMed ID: 34335972
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Molecular Image-Guided Cancer Radionuclide Therapy.
Gao D; Sun X; Gao L; Liu Z
Curr Drug Targets; 2015; 16(6):634-44. PubMed ID: 26028045
[TBL] [Abstract][Full Text] [Related]
10. Antibody-based Radiopharmaceuticals as Theranostic Agents: An Overview.
Sharma R; Suman SK; Mukherjee A
Curr Med Chem; 2022; 29(38):5979-6005. PubMed ID: 35674298
[TBL] [Abstract][Full Text] [Related]
11. Peptide radiopharmaceuticals for diagnosis and therapy.
Signore A; Annovazzi A; Chianelli M; Corsetti F; Van de Wiele C; Watherhouse RN
Eur J Nucl Med; 2001 Oct; 28(10):1555-65. PubMed ID: 11685500
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapy in nuclear medicine--current status and future prospects.
Oyen WJ; Bodei L; Giammarile F; Maecke HR; Tennvall J; Luster M; Brans B
Ann Oncol; 2007 Nov; 18(11):1782-92. PubMed ID: 17434893
[TBL] [Abstract][Full Text] [Related]
13. Radionuclide Therapies in Molecular Imaging and Precision Medicine.
Kendi AT; Moncayo VM; Nye JA; Galt JR; Halkar R; Schuster DM
PET Clin; 2017 Jan; 12(1):93-103. PubMed ID: 27863570
[TBL] [Abstract][Full Text] [Related]
14. Radiolabeled probes targeting tyrosine-kinase receptors for personalized medicine.
Altai M; Orlova A; Tolmachev V
Curr Pharm Des; 2014; 20(14):2275-92. PubMed ID: 24025099
[TBL] [Abstract][Full Text] [Related]
15. Imaging-guided targeted radionuclide tumor therapy: From concept to clinical translation.
Sun J; Huangfu Z; Yang J; Wang G; Hu K; Gao M; Zhong Z
Adv Drug Deliv Rev; 2022 Nov; 190():114538. PubMed ID: 36162696
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and preclinical evaluation of radiolabeled peptides for diagnosis and therapy.
Aloj L; Morelli G
Curr Pharm Des; 2004; 10(24):3009-31. PubMed ID: 15379665
[TBL] [Abstract][Full Text] [Related]
17. Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
Virgolini I; Traub T; Novotny C; Leimer M; Füger B; Li SR; Patri P; Pangerl T; Angelberger P; Raderer M; Burggasser G; Andreae F; Kurtaran A; Dudczak R
Curr Pharm Des; 2002; 8(20):1781-807. PubMed ID: 12171531
[TBL] [Abstract][Full Text] [Related]
18. Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer.
D'Huyvetter M; Xavier C; Caveliers V; Lahoutte T; Muyldermans S; Devoogdt N
Expert Opin Drug Deliv; 2014 Dec; 11(12):1939-54. PubMed ID: 25035968
[TBL] [Abstract][Full Text] [Related]
19. Radiopharmaceuticals in the elderly cancer patient: Practical considerations, with a focus on prostate cancer therapy: A position paper from the International Society of Geriatric Oncology Task Force.
Prior JO; Gillessen S; Wirth M; Dale W; Aapro M; Oyen WJG
Eur J Cancer; 2017 May; 77():127-139. PubMed ID: 28391026
[TBL] [Abstract][Full Text] [Related]
20. Theranostic Advances in Breast Cancer in Nuclear Medicine.
Vahidfar N; Aghanejad A; Ahmadzadehfar H; Farzanehfar S; Eppard E
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
